Human cytomegalovirus early infection, acute rejection, and major histocompatibility class II expression in transplanted lung: Molecular, immunocytochemical, and histopathologic investigations

Transplantation

Volumn 61, Issue 3, 1996, Pages 418-427

  Arbustini, Eloisa ^a,b   Morbini, Patrizia ^a   Grasso, Maurizia ^a   Diegoli, Marta ^a   Fasani, Roberta ^a   Porcu, Emanuele ^a   Banchieri, Nadia ^a   Perfetti, Vittorio ^a   Pederzolli, Carlo ^a   Grossi, Paolo ^a   Gasperina, Daniela Dalla ^a   Martinelli, Luigi ^a   Paulli, Marco ^a   Ernst, Manfred ^c   Plachter, Bodo ^d   Viganò, Mario ^a   Solcia, Enrico ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b Istituto di Anatomia Patologica   (Italy)

^c European Central Bank   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR3 ANTIGEN;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; GENE EXPRESSION; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG INFILTRATE; LUNG TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY;

ACUTE DISEASE; BASE SEQUENCE; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOPATHOGENIC EFFECT, VIRAL; DNA PRIMERS; DNA, VIRAL; GRAFT REJECTION; HLA-DR ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; LUNG TRANSPLANTATION; MOLECULAR SEQUENCE DATA; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION;

EID: 9044252307     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602150-00018     Document Type: Article

References (56)

1. Higenbottam T, Steqart S, Penketh A, Wallwork J. The diagnosis of lung rejection and opportunistic infection by transbronchial lung biopsy. Transplant Proc 1987; 19: 3777.
2. Cagle PT, Truong LD, Holland VA, Lawrence EC, Noon GP, Greenberg SD. Lung biopsy evaluation of acute rejection versus opportunistic infection in lung transplant patients. Transplantation 1989; 47: 713.
3. Burke CM, Glanville AR, Theodore J. Lung immunogenicity, rejection and obliterative bronchiolitis. Chest 1987; 92: 547.
4. Doherty PC, Allan W, Eichelberger P, Carding SR. Roles of αβ and γδ T cell subsets in viral immunity. Annu Rev Immunol 1992; 10: 123.
5. Chang SC, Hsu HK, Perng RP, Shiao GM, Lin CY. Increased expression of MHC class II antigens in rejecting canine lung allografts. Transplantation 1990; 49: 1158.
6. Borysiewicz LK, Graham S, Hickling J, Sissons JGP. Precursor frequency and stage specificity of human cytomegalovirus specific cytotoxic T cells. Eur J Immunol 1988; 18: 269.
7. Borysiewicz LK, Sissons JGP. Immune response to virus infected cells. Clin Immunol Allergy 1986; 6: 159.
8. Jacobson S, Sekaly RP, Jacobson CL, McFarland HF, Long EO. HLA class II restricted presentation of cytoplasmic measles virus antigen to cytotoxic T cells. J Virol 1989; 63: 1756.
9. 2 microglobulin. Science 1992; 255: 1576.
10. Lindsley MD, Torpey DJ, Rinaldo CRJ. HLA-DR restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. J Immunol 1986; 136: 3045.
11. Alp NJ, Allport TD, van Zanten J, Rodgers B, Sissons JGB, Borysiewicz LK. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early protein. J Virol 1991; 65: 4812.
12. Döcke WD, Prosch S, Fietze E, et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343: 268.
13. Ibrahim L, Dominguez M, Yacoub M. Primary human adult lung epithelial cells in vitro: response to interferon-γ and cytomegalovirus. Immunology 1993; 79: 119.
14. van Dorp WT, Jonges E, Bruggeman CA, Daha MR, van Es LA, van der Woude FJ. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 1989; 48: 469.
15. Sedmak DD, Roberts WH, Stephens RE, et al. Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression. Transplantation 1990; 49: 458.
16. Ustinov JA, Loginov RJ, Bruggeman CA, Van der Meide PH, Ahyry PJ, Lautenschlager IT. Cytomegalovirus induces class II expression in rat heart endothelial cells. J Heart Lung Transplant 1993; 12: 644.
17. Khoury EL, Pereira L, Greenspan FS. Induction of HLA DR expression on thyroid follicular cells by cytomegalovirus in vitro. Am J Pathol 1991; 138: 1209.
18. Sedmak DD, Guglielmo AM, Knight DA, Birmingham DS, Huang EH, Waldman WJ. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 1994; 144: 683.
19. Ng-Bautista CL, Sedmak DD. Cytomegalovirus infection is associated with absence of alveolar epithelial cell HLA class II antigen expression. J Infect Dis 1995; 171: 39.
20. Sherman LA, Chattopadhyay S. The molecular basis of allorecognition. Ann Rev Immunol 1993; 11: 385.
21. Arbustini E, Morbini P, Diegoli M, et al. Coexpression of aspartic proteinases and HLA-DR in human transplanted lung. Am J Pathol 1994; 145: 310.
22. Balthesen M, Messerle M, Reddehase MJ. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993; 67: 5360.
23. Yousem SA, Curley JM, Dauber J, et al. HLA-class II antigen expression in human heart-lung allografts. Transplantation 1990; 49: 991.
24. De Blic J, Peuchmaur M, Carnot F, et al. Rejection in lung transplantation: an immunohistochemical study of transbronchial biopsies. Transplantation 1992; 54: 639.
25. Arbustini E, Grasso M, Diegoli M, et al. La biopsia endomiocardica nel paziente cardiotrapiantato: stato dell'arte. G Ital Cardiol 1991; 21: 97.
26. Arbustini E, Grasso M, Diegoli M, et al. Histopathologic and molecular profile of human cytomegalovirus infections in patients with heart transplant. Am J Clin Pathol 1992; 98: 205.
27. Levin DC, Wicks AB, Ellis JH. Transbronchial lung biopsy via the fiberoptic bronchoscope. Am Rev Respir Dis 1974; 110: 4.
28. Arbustini E, Grasso M, Diegoli M, et al. Expression of tumor necrosis factor in human acute cardiac rejection. Am J Pathol 1991; 139: 709.
29. Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Transplant 1990; 9: 593.
30. Gerna G, Revello MG, Percivalle E, Zavattoni M, Parea M, Battaglia M. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 1990; 28: 2681.
31. Chee MS, Bankier AT, Beck S, et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 1990; 154: 125.
32. Ellinger S, Glockshuber R, Jahn G, Pluckthun A. Cleavage of procariotically expressed human immunodeficiency virus fusion proteins by factor Xa and amplification in Western blot (immunoblot) assays. J Clin Microbiol 1989; 27: 971.
33. Plachter B, Britt WJ, Vornhagen R, Stamminger T, Jahn G. Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalovirus using monoclonal antibodies generated against recombinant antigens. Virology 1993; 193; 642.
34. Stenberg RM, Depto AS, Fortney J, Nelson JA. Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol 1989; 63: 2699.
35. Stinski MF, Thomsen DR, Stenberg RM, Goldstein LC. Organization and expression of the immediate early genes of human cytomegalovirus. J Virol 1983; 46: 1.
36. Gibson W. Immediate-early proteins of human cytomegalovirus strains AD169, Davis and Towne differ in electrophoretic mobility. Virology 1981; 112: 350.
37. Wathen MW, Thomsen DR, Stinski MF. Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection. J Virol 1981; 38: 446.
38. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase techniques. J Histochem Cytochem 1981; 29: 577.
39. Van Noorden S, Stuart MC, Cheung A, Adams EF, Polak JM. Localization of human pituitary hormones by multiple immunoenzyme staining procedures using monoclonal and polyclonal antibodies. J Histochem Cytochem 1986; 34: 293.
40. Wathen MW, Stinski MF. Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate-early, early, and late times after infection. J Virol 1982; 41: 462.
41. Bauer HM, Ting Y, Greer CE, et al. Genital human Papillomavirus infection in female university students as determinated by a PCR-based method. JAMA 1991; 265: 472.
42. Gerna G, Revello MG, Percivalle E, Morini F. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 1992; 30: 1232.
43. Gilbert MJ, Riddell SR, Li CR, Greenberg PD. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J Virol 1993; 67: 3461.
44. Spector SA, Hirata KK, Neuman TR. Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome. J Infect Dis 1984; 150: 953.
45. Buffone GJ, Frost A, Samo T, Demmler GJ, Cagle PT, Lawrence CE. The diagnosis of CMV pneumonitis in lung and heart-lung transplant patients by PCR compared with traditional laboratory criteria. Transplantation 1993; 56: 342.
46. Flint A, Frank TS. Cytomegalovirus detection in lung transplant biopsy samples by polymerase chain reaction. J Heart Lung Transplant 1994; 13: 38.
47. Smith RL, Scott JP, Borysiewicz LK, et al. Cytomegalovirus infection in heart lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis 1991; 164: 1045.
48. Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 533.
49. Fend F, Prior C, Margreiter R, Mikuz G. Cytomegalovirus pneumonitis in heart lung transplant recipients: histopathology and clinicopathologic considerations. Hum Pathol 1990; 21: 918.
50. Scott JP, Higenbottam TW, Sharpies L, et al. Risk factors for obliterative bronchiolitis in heart lung transplant recipients. Transplantation 1991; 51: 813.
51. Burke CM, Glanville AR, Macoviak JA, O'Connell BM, Tazelaar HD, Baldwin JC. The spectrum of Cytomegalovirus infection following human heart lung transplantation. J Heart Transplant 1986; 5: 267.
52. Jonjic S, del Val M, Keil GM, Reddehasse MJ, Koszinowski UH. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. J Virol 1988; 62: 1653.
53. van Dorp WT, van Wieringen PAM, Marselis-Jonges E, et al. Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation 1993; 55: 1367.
54. Von Willebrand E, Petterson E, Ahonen J, Hayry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986; 42: 364.
55. Arnold JC, Portmann BC, O'Grady JG, Naoumov NV, Alexander GJ, Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology 1992; 16: 285.
56. Hall BM, Bishop GA, Diggin CG, Horvath JS, Philips J, Tiller DJ. Increased expression of HLA-DR antigens on renal tubular cells in renal transplant: relevance to the rejection response. Lancet 1984; 2: 247.